Antarctic
发表于 2025-3-26 23:22:02
http://reply.papertrans.cn/23/2220/221950/221950_31.png
glowing
发表于 2025-3-27 01:26:35
http://reply.papertrans.cn/23/2220/221950/221950_32.png
同步左右
发表于 2025-3-27 06:36:07
http://reply.papertrans.cn/23/2220/221950/221950_33.png
Parallel
发表于 2025-3-27 09:44:42
http://reply.papertrans.cn/23/2220/221950/221950_34.png
石墨
发表于 2025-3-27 14:33:11
B. N. Ghosh,Raman Jeet Singh,P. K. Mishrathrombotic events. Moreover, arterial FDG uptake is modifiable by anti-atherosclerotic treatments especially those with anti-inflammatory properties such as statins. Accordingly, FDG-PET/CT imaging is increasingly used as a surrogate imaging biomarker to monitor therapeutic efficacy of anti-atherosc
GEN
发表于 2025-3-27 20:03:41
http://reply.papertrans.cn/23/2220/221950/221950_36.png
mitten
发表于 2025-3-28 01:27:28
http://reply.papertrans.cn/23/2220/221950/221950_37.png
resistant
发表于 2025-3-28 03:07:15
Ultrasound Molecular Imaging of Endothelial Cell Activation and Damage in Atherosclerosisas stroke and acute coronary syndromes. The ability to image the structural, cellular, or biochemical signatures of high-risk plaque phenotype has been a major goal for essentially all forms of clinical and preclinical imaging. These efforts have been based on the need to better understand pathobiol
Substance-Abuse
发表于 2025-3-28 06:47:11
http://reply.papertrans.cn/23/2220/221950/221950_39.png
CARK
发表于 2025-3-28 11:32:06
Intravascular Molecular Imaging of Proteolytic Activityatients will suffer these complications. New strategies to define high-risk plaque biology in vivo hold promise to differentiate stable from vulnerable atherosclerotic plaques. Plaque proteolytic activity has emerged as a key target for identifying vulnerable plaques given its association with plaqu